Curious George

George Church has consistently positioned himself at genomics’ leading edge.

Written byAnna Azvolinsky
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

GEORGE CHURCH
Professor of Genetics, Harvard Medical School, Boston, MA Senior Associate,
Broad Institute of MIT and Harvard
PHOTO BY SETH KROLL
In 1973, after trying out two other groups, George Church finally found the perfect fit in Sung-Hou Kim’s X-ray crystallography lab, where he spent his second (and final) year as a Duke University undergraduate. “It was all of the things I was interested in—physics, math, biology, chemistry, and computers—in one. Kim had just come from MIT and was young and full of energy,” says Church, now a professor of genetics at Harvard University. “He saw a spark in me that few people had noticed before, and he treated me almost as an equal. I started to blossom in that lab.”

Church knew that he wanted to go to graduate school, and had already applied to the microbiology PhD program at Duke when he began to work with Kim. “I thought I should stay at the same university because I was young and immature.” Church began his PhD at Duke while continuing to work alongside Kim, with whom he would soon publish five papers, including one on modeling DNA-protein interactions and another on the three-dimensional structure of transfer RNAs. Twelve months into his microbiology PhD, Church decided instead to pursue a degree in biochemistry, but was booted out at the beginning of 1976. The biochemistry curriculum didn’t capture his interest any more than microbiology’s had, and after he’d flunked two courses, even Kim could not convince ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Published In

October 2016

30th Anniversary Issue

How life science research has changed since 1986

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies